Welcome to the mRNA Process Development & Manufacturing Summit
Accelerating mRNA Drug Substance Process Scale Up and Manufacturing
Built with biopharmaceutical industry insights, this in-person conference will bring together key opinion leaders to delve deep into the key remaining challenges associated with mRNA process scale up and manufacturing towards regulatory harmonization by optimizing in vitro transcription, purification and analytical validation mRNA drug substance.
With 220+ attendees from large pharma, innovative biotech and KOLs of academia who are ready to discuss how the future mRNA process development and manufacturing is shaping in accordance with regulatory expectations and emerging tools and technologies to support the development of scalable and commercially viable mRNA-based therapeutics and vaccines, join us in Boston to hear how they address the major challenges facing the industry.
Access the full event guide to learn more.